Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ALPROSTADIL COUPLED NITRIC OXIDE DONOR MEDICINE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/082470
Kind Code:
A1
Abstract:
Provided are an alprostadil coupled nitric oxide donor compound or a pharmaceutically acceptable salt thereof. The medicine is decomposed into two active ingredients, namely alprostadil and nitric oxide, in vivo, the pharmacological action is exerted in two ways respectively, and the therapeutic effect is achieved. The medicine can significantly enhance the acting strength of the medicine, and overcome the defects of weak continuous action, insufficient activity and the like caused by large vascular irritation and short half-life period of alprostadil.

Inventors:
LU ZHUOMIN (CN)
WANG TIANYU (CN)
LI JINHUI (CN)
TAN FENGGUI (CN)
HUANG XIAMENG (CN)
JIANG SHENG (CN)
WANG TING (CN)
Application Number:
PCT/CN2023/072259
Publication Date:
April 25, 2024
Filing Date:
January 16, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU KEMROCMED CO LTD (CN)
GUANGZHOU KEMROCMED BIOTECH CO LTD (CN)
International Classes:
C07D413/12; A61K31/5575; A61P9/10; A61P9/14; C07C405/00
Foreign References:
CN109988089A2019-07-09
US20090088366A12009-04-02
CN114025768A2022-02-08
US5625083A1997-04-29
CN113943266A2022-01-18
CN104470510A2015-03-25
Other References:
SERKOV I. V. ET AL.: "1,3-Dinitrates of Cyclooxygenase Metabolites of Endocannabinoid 2-Arachidonoylglycerol. Synthesis and Properties", RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, vol. 35, no. 2, 2009-12-31, pages 225 - 232, XP055776327, DOI: 10.1134/S1068162009020113
Attorney, Agent or Firm:
BEIJING JUNYOU INTELLECTUAL PROPERTY AGENCY (GENERAL PARTNERSHIP) (CN)
Download PDF: